Zabofloxacin
- Generic Name
- Zabofloxacin
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C19H20FN5O4
- CAS Number
- 219680-11-2
- Unique Ingredient Identifier
- LV66BA6V2G
- Background
Zabofloxacin has been used in trials studying the treatment of Community Acquired Pneumonia and Chronic Obstructive Pulmonary Disease.
- Associated Conditions
- -
- Associated Therapies
- -
A Study to Evaluate Efficacy and Safety Profile of Zabofloxacin Tablet 400mg and Moxifloxacin Tablet 400mg
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2012-08-06
- Last Posted Date
- 2014-10-13
- Lead Sponsor
- Dong Wha Pharmaceutical Co. Ltd.
- Target Recruit Count
- 345
- Registration Number
- NCT01658020
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of
Safety and Efficacy Study of Oral Zabofloxacin in Community Acquired Pneumonia
Phase 2
Terminated
- Conditions
- Interventions
- First Posted Date
- 2010-03-05
- Last Posted Date
- 2012-05-07
- Lead Sponsor
- IASO Pharma Inc.
- Target Recruit Count
- 48
- Registration Number
- NCT01081964
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath